{
    "startDate": "2017-04-01",
    "endDate": "2017-12-31",
    "year": "2018",
    "quarter": "Q3",
    "symbol": "MYOV",
    "data": {
        "bs": [
            {
                "label": "Net change in cash",
                "concept": "Cash",
                "unit": "usd",
                "value": 128873000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 5279000
            },
            {
                "label": "Income tax receivable",
                "concept": "IncomeTaxesReceivable",
                "unit": "usd",
                "value": 607000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 134759000
            },
            {
                "label": "Deferred tax assets",
                "concept": "DeferredIncomeTaxAssetsNet",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Furniture and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 1120000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 2098000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 137977000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2091000
            },
            {
                "label": "Total accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 20953000
            },
            {
                "label": "Due to Roivant Sciences Ltd. and Roivant Sciences, Inc.",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 3683000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 26727000
            },
            {
                "label": "Takeda warrant liability",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Deferred rent",
                "concept": "DeferredRentCreditNoncurrent",
                "unit": "usd",
                "value": 372000
            },
            {
                "label": "Deferred interest payable",
                "concept": "InterestPayableCurrentAndNoncurrent",
                "unit": "usd",
                "value": 105000
            },
            {
                "label": "Current interest rate",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 28575000
            },
            {
                "label": "Liabilities and Shareholders\u2019 Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 55779000
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common shares, par value $0.000017727 per share, 564,111,242 shares authorized, 60,989,395 and 60,275,757 issued and outstanding at December 31, 2017 and March 31, 2017, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Common shares subscribed",
                "concept": "CommonStockShareSubscribedButUnissuedSubscriptionsReceivable",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 262510000
            },
            {
                "label": "Accumulated other comprehensive (loss) income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -91000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -180221000
            },
            {
                "label": "Shareholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 82198000
            },
            {
                "label": "Liabilities and Shareholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 137977000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -95002000
            },
            {
                "label": "Equity Award [Domain]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 8243000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 167000
            },
            {
                "label": "Amortization of debt discount and issuance costs",
                "concept": "AmortizationOfFinancingCostsAndDiscounts",
                "unit": "usd",
                "value": 390000
            },
            {
                "label": "Acquisition of in-process research and development",
                "concept": "ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Changes in the fair value of the Takeda warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": 231000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 2058000
            },
            {
                "label": "Deferred tax assets",
                "concept": "IncreaseDecreaseInDeferredIncomeTaxes",
                "unit": "usd",
                "value": -208000
            },
            {
                "label": "Income tax receivable",
                "concept": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable",
                "unit": "usd",
                "value": -502000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherCurrentAssets",
                "unit": "usd",
                "value": 2098000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -1238000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 8838000
            },
            {
                "label": "Due to Roivant Sciences Ltd. and Roivant Sciences, Inc.",
                "concept": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 653000
            },
            {
                "label": "Deferred rent",
                "concept": "IncreaseDecreaseInIncomeTaxesReceivable",
                "unit": "usd",
                "value": -259000
            },
            {
                "label": "Deferred interest payable",
                "concept": "IncreaseDecreaseInInterestPayableNet",
                "unit": "usd",
                "value": 105000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -82266000
            },
            {
                "label": "Purchases of furniture and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 375000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -375000
            },
            {
                "label": "Cash proceeds from issuance of common shares in initial public offering, net of underwriting discount",
                "concept": "ProceedsFromIssuanceInitialPublicOffering",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Initial public offering costs paid",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash proceeds from debt financings, net of financing costs",
                "concept": "ProceedsFromDebtNetOfIssuanceCosts",
                "unit": "usd",
                "value": 28803000
            },
            {
                "label": "Cash proceeds from issuance of common shares to NovaQuest, net of issuance costs",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 1857000
            },
            {
                "label": "Cash capital contribution from Roivant Sciences Ltd.",
                "concept": "ProceedsFromContributionsFromParent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Stock option exercises",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 16000
            },
            {
                "label": "Due to Roivant Sciences Ltd. and Roivant Sciences, Inc. for amounts paid on behalf of the Company",
                "concept": "myov:RepaymentsOfAmountsDueToRelatedPartyForAmountsPaidOnBehalfOfEntity",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 30676000
            },
            {
                "label": "Net change in cash",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": -51965000
            },
            {
                "label": "Deferred initial public offering costs, unpaid",
                "concept": "myov:OfferingCostsIncurredButNotYetPaid",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Acquisition of in-process research and development",
                "concept": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Deferred financing costs, unpaid",
                "concept": "myov:FinancingandStockIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction",
                "unit": "usd",
                "value": 137000
            },
            {
                "label": "Warrant issued to Hercules",
                "concept": "myov:NoncashTransactionWarrantsIssued",
                "unit": "usd",
                "value": 481000
            }
        ],
        "ic": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -95002000
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": -231000
            },
            {
                "label": "Total other comprehensive loss",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": -231000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -95233000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 76753000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 16963000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 93716000
            },
            {
                "label": "Changes in the fair value of the Takeda warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 904000
            },
            {
                "label": "Other income",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 225000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -94395000
            },
            {
                "label": "Income tax (benefit) expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 607000
            },
            {
                "label": "Net loss per common share \u2014 basic and diluted (in USD per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -1.6
            },
            {
                "label": "Weighted average common shares outstanding \u2014 basic and diluted (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 59446140
            }
        ]
    }
}